Unknown

Dataset Information

0

Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.


ABSTRACT: Canine parvovirus (CPV) has been considered to be an important pathogen, which can cause acute infectious disease in canids. Although current vaccines are effective in preventing CPV infection, safety problems still remain unsolved. In this study, a subunit vaccine against CPV based on virus-like particles (VLPs) with good safety and immunogenicity is reported. Soluble CPV VP2 protein was produced by co-expression of chaperone trigger factor (Tf16) in Escherichia coli (E.coli), and assembled into CPV VLPs which could be affected by NaCl and pH. At 250 mM NaCl pH 8.0, the VLPs co-expressed with Tf16 had similar size (25 nm) and shape with the authentic virus capsid under the transmission electron microscopy (TEM), which is also in accordance with the dynamic light scattering (DLS) data. Immunization with these particles could induce high-titer hemagglutination inhibition (1:12288) and neutralizing antibodies (1:6144) in guinea pigs. Splenic cells of them could secrete IFN-? and IL-4 after stimulation by CPV. Thus, the VLPs produced by the new approach with high yield and immunogenicity could be a potential candidate for CPV vaccine.

SUBMITTER: Nan L 

PROVIDER: S-EPMC6008937 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.

Nan Liangliang L   Liu Yunchao Y   Ji Pengchao P   Feng Hua H   Chen Chen C   Wang Juan J   Liu Dongmin D   Cui Yinglei Y   Wang Yanwei Y   Li Yafei Y   Zhou Enmin E   Zhang Gaiping G  

Virology journal 20180619 1


Canine parvovirus (CPV) has been considered to be an important pathogen, which can cause acute infectious disease in canids. Although current vaccines are effective in preventing CPV infection, safety problems still remain unsolved. In this study, a subunit vaccine against CPV based on virus-like particles (VLPs) with good safety and immunogenicity is reported. Soluble CPV VP2 protein was produced by co-expression of chaperone trigger factor (Tf16) in Escherichia coli (E.coli), and assembled int  ...[more]

Similar Datasets

| S-EPMC8304427 | biostudies-literature
| S-EPMC7301529 | biostudies-literature
| S-EPMC5512735 | biostudies-literature
| S-EPMC4800397 | biostudies-literature
| S-EPMC1716759 | biostudies-literature
| S-EPMC4466328 | biostudies-literature
| S-EPMC10748189 | biostudies-literature
| S-EPMC7150758 | biostudies-literature
| S-EPMC4580430 | biostudies-literature